Beta
Back to LLY.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • Revenue by Segments
  • EPS
  • EPS Diluted
  • Revenue
  • Operation Income
  • Net Income
  • Operating Expenses
  • Cash Flow
  • Cash & Debt
  • Current Contract Liabilities
cash-flow-chart

LLY Cash Flow

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

In Q4'25, Eli Lilly's (LLY) operating cash flow reached $3.22B USD, reflecting a robust quarter driven by strong operational performance, while free cash flow stood at $678M USD, indicating solid liquidity after capital expenditures. This latest data point marks a sequential decline from the exceptional Q3'25 operating cash flow of $8.84B USD but remains positive year-over-year. Over the period from Q1'23 to Q4'25, operating cash flow exhibited significant volatility, starting at $1.73B USD in Q1'23, dipping to a negative -$312M USD in Q4'23, and surging to a peak of $8.84B USD in Q3'25 amid accelerating growth trends likely tied to product demand. Free cash flow followed a similar volatile pattern, with early negatives like -$1.38B USD in Q4'23 giving way to strong positives, peaking at $6.75B USD in Q3'25, highlighting improving capital efficiency and overall cash generation momentum in recent quarters despite occasional dips.